Gabapentin Capsule
Product Images NDC 65162-102

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 65162-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Gabapentin Capsules Usp 1)

A formula table for estimating creatinine clearance (CLCr) in patients. It includes the variables age (years), weight (kg), and serum creatinine (mg/dL), with a multiplication adjustment factor of 0.85 specified for female patients.*

FDA Label Image

10 (Gabapentin Capsules Usp 10)

Gabapentin Capsules, USP 100 mg label from Amneal Pharmaceuticals LLC. The label indicates a 30 capsule count, oral dosage form, and Rx only status. It includes storage instructions, manufacturer and distributor information, a barcode, and a QR code linking to the medication guide.*

FDA Label Image

10 (Gabapentin Capsules Usp 11)

Label for Gabapentin Capsules USP 300 mg by Amneal Pharmaceuticals LLC. The label states each capsule contains 300 mg gabapentin and comes in a package of 30 capsules. It includes storage instructions, prescribing information, and directions to dispense the Medication Guide to the patient. The label features a QR code and bar code with manufacturer and distributor details.*

FDA Label Image

10 (Gabapentin Capsules Usp 12)

Gabapentin Capsules, USP 400 mg oral capsules label by Amneal Pharmaceuticals LLC. The label indicates a package of 30 capsules for prescription use only. It includes storage instructions, manufacturer details, and a QR code linking to the medication guide.*

FDA Label Image

Chem Structure (Gabapentin Capsules Usp 2)

Chemical structure of gabapentin, showing a cyclohexane ring bonded to aminomethyl and carboxymethyl groups.*

FDA Label Image

10 (Gabapentin Capsules Usp 3)

A line graph depicting the mean pain score over an 8-week period comparing Placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows the mean pain score from 0 to 10. Two periods are highlighted: a 4-week dose titration followed by a 4-week fixed dose. Gabapentin shows a notable decrease in mean pain score compared to placebo.*

FDA Label Image

10 (Gabapentin Capsules Usp 4)

A line chart showing mean pain scores over seven weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. It includes a 3-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing more in the Gabapentin groups compared to placebo.*

FDA Label Image

10 (Gabapentin Capsules Usp 5)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) at different doses across two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated for comparisons with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4 (Gabapentin Capsules Usp 6)

A scatter plot showing percentage difference on the y-axis versus daily dose in mg on the x-axis. The graph compares studies labeled a, b, and c at daily doses 600 mg, 900 mg, 1200 mg, and 1800 mg, with points indicating differences ranging approximately from 7% to 18%. Study a is shown in black squares, Study b in gray squares, and Study c in white squares.*

FDA Label Image

10 (Gabapentin Capsules Usp 7)

Label for Gabapentin Capsules, USP 100 mg by Amneal Pharmaceuticals LLC. The label provides NDC 65162-101-03 and states the product is Rx only with 30 capsules in the package. It includes directions for pharmacists to dispense the Medication Guide, storage instructions, and manufacturer and distributor details including Amneal Pharmaceuticals Pvt. Ltd. and Amneal Pharmaceuticals LLC.*

FDA Label Image

10 (Gabapentin Capsules Usp 8)

Gabapentin Capsules, USP 300 mg label from Amneal Pharmaceuticals LLC. The label specifies 30 capsules in the package and includes storage instructions and manufacturer information. It instructs pharmacists to dispense the Medication Guide to each patient and provides a QR code linking to the Med Guide.*

FDA Label Image

10 (Gabapentin Capsules Usp 9)

Label for Gabapentin Capsules, USP 400 mg by Amneal Pharmaceuticals LLC. The label indicates a prescription-only oral capsule product containing 400 mg of gabapentin per capsule, with a package size of 30 capsules. It includes storage instructions, manufacturer and distributor information, a pharmacist notice, and a QR code for the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.